Page 12 of 15 SEC Filing Item 2 (d). Title of Class of Securities: Common Stock, $.001 Par
Value Per Share (the “Common Stock”)
Item 2 (e). CUSIP Number: 189464100
Item 3. Not applicable.
Item 4. Ownership.
The information required by Items 4(a) – (c) is set
forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting
Person.
Collectively, HealthCor Offshore Master Fund, L.P. and
HealthCor Sanatate Offshore Master Fund, L.P. (each a “Fund” and together, the “Funds”) are the beneficial
owners of a total of 2,000,000 shares of the Common Stock of the Issuer.
HealthCor Offshore GP, LLC is the general partner of
HealthCor Offshore Master Fund, L.P. Accordingly, HealthCor Offshore GP, LLC may be deemed to beneficially own the shares of Common
Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor
Offshore GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor
Offshore Master Fund, L.P.
HealthCor Offshore II GP, LLC is the general partner
of HealthCor Sanatate Offshore Master Fund, L.P. Accordingly, HealthCor Offshore II GP, LLC may be deemed to beneficially own the
shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P. HealthCor Group, LLC is the
managing member of HealthCor Offshore II GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that
are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P.
By virtue of its position as the investment manager
of the Funds, HealthCor Management, L.P. may be deemed a beneficial owner of all the shares of Common Stock owned by the Funds.
HealthCor Associates, LLC is the general partner of HealthCor Management, L.P. and thus may also be deemed to beneficially own
the shares of Common Stock that are beneficially owned by the Funds.
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| Item 2 (d). | Title of Class of Securities: Common Stock, $.001 Par Value Per Share (the “Common Stock”) |
| Item 2 (e). | CUSIP Number: 189464100 |
| Item 3. | Not applicable. |
| Item 4. | Ownership. |
The information required by Items 4(a) – (c) is set
forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting
Person.
Collectively, HealthCor Offshore Master Fund, L.P. and
HealthCor Sanatate Offshore Master Fund, L.P. (each a “Fund” and together, the “Funds”) are the beneficial
owners of a total of 2,000,000 shares of the Common Stock of the Issuer.
HealthCor Offshore GP, LLC is the general partner of
HealthCor Offshore Master Fund, L.P. Accordingly, HealthCor Offshore GP, LLC may be deemed to beneficially own the shares of Common
Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor
Offshore GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor
Offshore Master Fund, L.P.
HealthCor Offshore II GP, LLC is the general partner
of HealthCor Sanatate Offshore Master Fund, L.P. Accordingly, HealthCor Offshore II GP, LLC may be deemed to beneficially own the
shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P. HealthCor Group, LLC is the
managing member of HealthCor Offshore II GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that
are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P.
By virtue of its position as the investment manager
of the Funds, HealthCor Management, L.P. may be deemed a beneficial owner of all the shares of Common Stock owned by the Funds.
HealthCor Associates, LLC is the general partner of HealthCor Management, L.P. and thus may also be deemed to beneficially own
the shares of Common Stock that are beneficially owned by the Funds.
